Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Vascular Burden, Amyloid, and Tau on Cognitive Impairment
NCT04309253Phase 2Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Sep 2018
- Primary completion
- May 2024
- Countries
- 1
01
Overview
Phase 2, open-label trial (5 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoints: Clinical Dementia Rating-Sum of Boxes change score at 1.5 years and Dementia conversion rate at 1.5 years. Status: unknown.
Beyond the preview
Go deeper on NCT04309253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04309253.